Published in Medical Letter on the CDC and FDA, July 11th, 2004
The new findings provide a basis for quantifying costs and assessing effectiveness of different thyroid screening strategies for reproductive-age women.
Previous research has shown that low levels of thyroid hormone in pregnant women can cause mildly impaired development in their children. As a result, some experts have advocated screening women of childbearing age for thyroid disease.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.